Clinical trial
Intestinal Decontamination With Rifaximin. Effects on the Inflammatory and Circulatory State in Patients With Cirrhosis and Ascites - A Randomised Controlled Clinical Study
NCT01769040 is registered in ClinicalTrials.gov with Copenhagen University Hospital, Hvidovre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intestinal Decontamination With Rifaximin. Effects on the Inflammatory and Circulatory State in Patients With Cirrhosis and Ascites - A Randomised Controlled Clinical Study
- Lead sponsor
- Copenhagen University Hospital, Hvidovre
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- January 31, 2016
- Enrollment
- 54 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.